Brokerages Set Sotera Health Company (NASDAQ:SHC) Target Price at $20.43

Sotera Health Company (NASDAQ:SHC) has been given an average rating of “Moderate Buy” by the eleven brokerages that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $20.4286.

SHC has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. William Blair initiated coverage on Sotera Health in a research note on Thursday, December 18th. They issued an “outperform” rating for the company. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and raised their target price for the company from $17.00 to $24.00 in a research report on Friday, January 9th. Royal Bank Of Canada assumed coverage on Sotera Health in a research note on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price on the stock. Finally, Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a report on Thursday, January 8th.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares in the company, valued at $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 47.55% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

Several large investors have recently modified their holdings of SHC. IFP Advisors Inc raised its holdings in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC bought a new position in Sotera Health during the fourth quarter valued at $27,000. True Wealth Design LLC increased its position in Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after buying an additional 1,456 shares during the last quarter. Eurizon Capital SGR S.p.A. purchased a new stake in Sotera Health in the fourth quarter worth $40,000. Finally, Versant Capital Management Inc raised its stake in shares of Sotera Health by 117.6% in the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock valued at $40,000 after buying an additional 1,370 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Down 1.0%

Sotera Health stock opened at $13.92 on Monday. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46. The firm’s 50-day simple moving average is $17.52 and its 200 day simple moving average is $16.80. The stock has a market cap of $3.96 billion, a PE ratio of 51.56 and a beta of 1.84.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The firm had revenue of $303.44 million during the quarter, compared to analyst estimates of $300.68 million. During the same quarter last year, the business posted $0.21 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Research analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.